Log in to save to my catalogue

Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin c...

Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_125c22dc5c4c435c863b8450ee8af4ed

Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin clearance

About this item

Full title

Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin clearance

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2022-05, Vol.19 (1), p.128-128, Article 128

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Vascular dementia (VAD) is the second most common type of dementia lacking effective treatments. Pentoxifylline (PTX), a nonselective phosphodiesterase inhibitor, displays protective effects in multiple cerebral diseases. In this study, we aimed to investigate the therapeutic effects and potential mechanisms of PTX in VAD.
Bilateral common carot...

Alternative Titles

Full title

Pentoxifylline alleviates ischemic white matter injury through up-regulating Mertk-mediated myelin clearance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_125c22dc5c4c435c863b8450ee8af4ed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_125c22dc5c4c435c863b8450ee8af4ed

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-022-02480-4

How to access this item